Cisco is up nearly 50% this year and just raised its AI order target by 80%, yet the stock sits well below its 52-week high.

The Kenvue spinoff came at a key moment, as J&J prepared to lose exclusivity of its blockbuster immunology drug Stelara. At ...

All three pharma giants have left the S&P 500 in the dust, but surging returns and strong fundamentals tell very different ...

Coinbase executives admitted Base has lost credibility with crypto users, even as the blockchain leads the industry in ...

Arch Capital Group (ACGL) has drawn fresh attention after a 9.7% gain over the past month, outpacing both the Zacks S&P 500 ...

IREN stock has shed 41% in a single month alongside every major miner-turned-AI-infrastructure name, but a $3.4 billion ...

Why is Coinbase joining that big coalition? Circle is the only company that mints and manages USDC. Circle also generates ...

Telix Pharmaceuticals has opened a radiopharmaceutical facility in Melbourne, Australia, to expedite the delivery of new cancer treatments.

Current and former tech leaders say the CEO's candid response to the tech giant's disappointing quarter offers a lesson for ...

J&J’s shares ticked down as oncology sales missed expectations. Elsewhere, AstraZeneca bet $600 million on a lung cancer drug and a pair of biotechs snagged two of the year’s top venture rounds.